The Effect of Bcrp1 (Abcg2) on the In vivo Pharmacokinetics and Brain Penetration of Imatinib Mesylate (Gleevec): Implications for the Use of Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors to Enable the Brain Penetration of Imatinib in Patients
2005 ◽
Vol 65
(7)
◽
pp. 2577-2582
◽
2007 ◽
Vol 13
(21)
◽
pp. 6440-6449
◽
2009 ◽
Vol 37
(5)
◽
pp. 946-955
◽
2009 ◽
Vol 36
(3)
◽
pp. 239-246
◽
2015 ◽
Vol 33
(5)
◽
pp. 1012-1019
◽
Keyword(s):
Keyword(s):
2009 ◽
Vol 29
(6)
◽
pp. 1079-1083
◽
Keyword(s):
2013 ◽
Vol 710
(1-3)
◽
pp. 20-28
◽